Nuwellis (NUWE) Liabilities and Shareholders Equity (2011 - 2026)

Nuwellis (NUWE) reported Liabilities and Shareholders Equity of $7.0 million for Q1 2026, down 0.64% on a YoY basis from $7.0 million in Q1 2025, and up 13.78% quarter-over-quarter from $6.1 million in Q4 2025.

Nuwellis (NUWE) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends

Nuwellis has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $7.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 0.64% year-over-year to $7.0 million; the trailing twelve-month figure through Mar 2026 stood at $30.3 million (up 1.6% YoY), and the FY2025 full-year result was $6.1 million, down 37.98% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $7.0 million, up from $6.1 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $26.1 million in Q1 2022, with the low at $6.1 million in Q4 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $12.5 million across 5 years, with a median of $9.8 million in 2023.
  • Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity sank 63.95% — and 2025, when it soared 48.65%.
  • Nuwellis' Liabilities and Shareholders Equity stood at $24.7 million in 2022, then plunged by 60.4% to $9.8 million in 2023, then increased by 0.96% to $9.9 million in 2024, then sank by 37.98% to $6.1 million in 2025, then advanced by 13.78% to $7.0 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $7.0 million (Q1 2026), $6.1 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 110.43 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 46.29 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 37.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 10.74 Bn
10 Nuwellis 279,710.00 -1.80 Mn 1.68 Mn 6.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.96 Mn
Dec 31, 2025 6.12 Mn
Sep 30, 2025 7.98 Mn
Jun 30, 2025 9.20 Mn
Mar 31, 2025 7.01 Mn
Dec 31, 2024 9.86 Mn
Sep 30, 2024 6.73 Mn
Jun 30, 2024 6.19 Mn
Mar 31, 2024 6.66 Mn
Dec 31, 2023 9.77 Mn
Sep 30, 2023 11.43 Mn
Jun 30, 2023 15.55 Mn
Mar 31, 2023 18.48 Mn
Dec 31, 2022 24.67 Mn
Sep 30, 2022 18.44 Mn
Jun 30, 2022 22.00 Mn
Mar 31, 2022 26.11 Mn
Dec 31, 2021 30.42 Mn
Sep 30, 2021 34.10 Mn
Jun 30, 2021 29.64 Mn